缺氧促进骨髓瘤细胞表达IL-32,高表达与较差生存和骨丢失相关
本研究在骨髓瘤细胞中发现新型炎性细胞因子IL-32,其高基因表达与较差生存相关,且骨病患者表达高于无骨病患者。骨髓瘤细胞通过细胞外囊泡分泌IL-32,该囊泡及重组人IL-32在体内外均促进破骨细胞分化,且该活性依赖IL-32。缺氧以缺氧诱导因子1α依赖方式增加IL-32表达,患者样本中IL-32高表达与缺氧特征相关。
要点
- IL-32在部分原代骨髓瘤细胞和骨髓瘤细胞系中表达,高表达与较差生存相关。
- 骨病患者骨髓瘤细胞IL-32基因表达高于无骨病患者。
- 骨髓瘤细胞来源细胞外囊泡及重组人IL-32在体内外促进破骨细胞分化,且囊泡活性依赖IL-32。
核心结论
- 靶向IL-32可能对部分骨髓瘤患者的骨髓瘤骨病治疗有益。
研究设计与样本
- 研究纳入原代骨髓瘤细胞、骨髓瘤细胞系及患者样本,进行基因表达与生存关联分析、细胞外囊泡分泌与功能实验、体内外破骨细胞分化实验及缺氧调控机制研究。
主要发现
- 浆细胞中IL-32基因高表达与骨髓瘤较差生存相关。
- 骨病患者IL-32基因表达高于无骨病患者。
- 骨髓瘤细胞通过细胞外囊泡分泌IL-32,该囊泡及重组人IL-32在体内外均促进破骨细胞分化。
- 细胞外囊泡的促破骨细胞分化活性依赖IL-32。
- 缺氧以缺氧诱导因子1α依赖方式增加浆细胞IL-32信使RNA和蛋白水平,患者样本中IL-32高表达与缺氧特征相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Multiple myeloma (MM) is a hematologic cancer characterized by expansion of malignant plasma cells in the bone marrow. Most patients develop an osteolytic bone disease, largely caused by increased osteoclastogenesis. The myeloma bone marrow is hypoxic, and hypoxia may contribute to MM disease progression, including bone loss. Here we identified interleukin-32 (IL-32) as a novel inflammatory cytokine expressed by a subset of primary MM cells and MM cell lines. We found that high IL-32 gene expression in plasma cells correlated with inferior survival in MM and that IL-32 gene expression was higher in patients with bone disease compared with those without. IL-32 was secreted from MM cells in extracellular vesicles (EVs), and those EVs, as well as recombinant human IL-32, promoted osteoclast differentiation both in vitro and in vivo. The osteoclast-promoting activity of the EVs was IL-32 dependent. Hypoxia increased plasma-cell IL-32 messenger RNA and protein levels in a hypoxia-inducible factor 1α-dependent manner, and high expression of IL-32 was associated with a hypoxic signature in patient samples, suggesting that hypoxia may promote expression of IL-32 in MM cells. Taken together, our results indicate that targeting IL-32 might be beneficial in the treatment of MM bone disease in a subset of patients.
引用
- Zahoor M, Westhrin M, Aass KR, et al. Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss. Blood Adv. 2017. PMID: 29296919. doi:10.1182/bloodadvances.2017010801
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。